LANREOTIDE [484169]



LANREOTIDE

No image available
SMILES CC(C)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](NC(=O)[C@H](N)Cc2ccc3ccccc3c2)CSSC[C@@H](C(=O)N[C@H](C(N)=O)[C@@H](C)O)NC1=O
InChIKey PUDHBTGHUJUUFI-SCTWWAJVSA-N
Sequence None
HELM PEPTIDE1{[dNal].C.Y.[dW].K.V.C.T.[am]}$PEPTIDE1,PEPTIDE1,7:R3-2:R3$$$

Chemical Properties

Hydrogen bond acceptors 14
Hydrogen bond donors 13
Rotatable bonds 17
Log P 0.822
Molecular weight (Da) 1095.5

Database connections

Structure pdb 9IK9 7XAV
Model (Boltz2) SST2 SST5
GPCRdb related ligands

Bioactivities

Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database
Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database

LANREOTIDE

No image available

Drug properties

Molecular type Peptide
Physiological/Surrogate Surrogate
Approved drug Yes

Distribution across phases (no. indications)

Phase I 0
Phase II 12
Phase III 12
Phase IV 6

Database connections

Structure pdb 9IK9 7XAV
Model (Boltz2) SST2 SST5
GPCRdb related ligands

Sankey plot

Drug Information

Target Disease
Gene Protein Receptor family Ligand type Class Name Phase ICD11 ATC Association score